Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Kintscher

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|November 18, 2010
[New targets for blood pressure lowering in diabetic patients?]U Kintscher
Acta Diabetologica|May 4, 2005
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockersU Kintscher, T Unger
Deutsche Medizinische Wochenschrift (1946)|May 10, 2008
[Aliskiren hemifumarate]K Kappert, T Unger, U Kintscher
Deutsche Medizinische Wochenschrift (1946)|November 22, 2012
[Hypertension 2012--still a challenge]S A Potthoff, U Wenzel, U Kintscher
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]C Butter, U Kintscher, A Waurick, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytesU Kintscher, S Wakino, S Kim, et al.
The Journal of Biological Chemistry|May 10, 2000
Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cellsS Wakino, U Kintscher, S Kim, et al.
Diabetes, Obesity & Metabolism|September 8, 2009
The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenationH Kilter, M Werner, C Roggia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cellsU Kintscher, S Wakino, S Kim, et al.
The Journal of Biological Chemistry|April 15, 2000
Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cellsS Goetze, U Kintscher, H Kawano, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|November 18, 2010
[New targets for blood pressure lowering in diabetic patients?]U Kintscher
Acta Diabetologica|May 4, 2005
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockersU Kintscher, T Unger
Deutsche Medizinische Wochenschrift (1946)|May 10, 2008
[Aliskiren hemifumarate]K Kappert, T Unger, U Kintscher
Deutsche Medizinische Wochenschrift (1946)|November 22, 2012
[Hypertension 2012--still a challenge]S A Potthoff, U Wenzel, U Kintscher
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]C Butter, U Kintscher, A Waurick, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytesU Kintscher, S Wakino, S Kim, et al.
The Journal of Biological Chemistry|May 10, 2000
Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cellsS Wakino, U Kintscher, S Kim, et al.
Diabetes, Obesity & Metabolism|September 8, 2009
The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenationH Kilter, M Werner, C Roggia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cellsU Kintscher, S Wakino, S Kim, et al.
The Journal of Biological Chemistry|April 15, 2000
Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cellsS Goetze, U Kintscher, H Kawano, et al.
Pageof 2